|Articles|May 7, 2023
- Pharmaceutical Executive: May 2023
- Volume 43
- Issue 5
Pharmaceutical Executive, May 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
From Science to Strategy | 2023 Emerging Pharma Leaderover 3 years ago
Committed to the Cause | 2023 Emerging Pharma Leaderover 3 years ago
A Knack for Problem-Solving | 2023 Emerging Pharma Leaderover 3 years ago
Mission-Fueled Mindset | 2023 Emerging Pharma Leaderover 3 years ago
Rejuvenating Lives | 2023 Emerging Pharma Leaderover 3 years ago
Optimized for Growth? Revenue Management in Pharmaover 3 years ago
Preparing for the End of the COVID Health Emergencyover 3 years ago
AI is a Tool, Not a Replacement for Employeesover 3 years ago
Ratings and Rankings: ESG Fundamentals for Pharma LeadersAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion
3
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
4
Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences
5

